EZH2 and head and neck squamous cell carcinoma: To examine whether EZH2 can specifically regulate the expression of the cholesterol synthesis pathway by modulating H3K27me3 levels, HNSCC cells were incubated with the EZH2-specific inhibitor EPZ6438.